ForumIAS LATEST
- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
Contents
What is the news?
A recent report Pharma Industry: Trends and Prospects has identified various gaps in Pharma Industry of India due to its dependence on China for API’s.
What is an API?
- Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs.
- The active ingredient(AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.
Findings of the report
- Nearly 70% of the country’s APIs are imported from China
- This dependence is around 90% for certain life-saving antibiotics such as cephalosporins, azithromycin and penicillin
- There are gaps in diagnostic services in India, especially in rural India. It caused anxieties among the population regarding procuring medicines, arranging COVID-19 tests and treatment
Recommendations
- Enhance expenditure on health care system– The overall spending on health varied from 1.3% of the gross domestic product in 2010-11 to 1.5% and 1.8% of the GDP for 2019-20 and for 2020-21. This needs to be increased
- Use digital technology– It urged states to make digital technology accessible in rural areas as it can serve as “a catalytic element of the transformation” of the healthcare scenario in India
- Promoting best state practices at national level
- The industry should explore new and innovative options to generate and sustain new revenue streams.
Implications of the findings
India’s import dependency on China for Active Pharmaceutical Ingredient (API) is leading to shortage of equipment, including small- and large-scale bioreactors and fermenters.
This dependency on China, amid rising border tensions with it, also presents a threat to India’s public health security.
It must be noted that during COVID pandemic, due to increased demand, the prices of APIs shot up pretty quickly causing problems for India.
Hence, it is a high time that the country explored ways to develop inputs indigenously.
